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Results: Aggrecan degradation and its inhibition demonstrated
cross-correlation between bovine articular cartilage explants as-
sayed via DMMB proteoglycan assay and IA/LC/MS/MS assays.
Dose-dependent reduction of the ARGS biomarker was also
demonstrated in human articular cartilage explants. The ARGS
biomarker was further detected in human urine analyzed by
IA/LC/MS/MS with a high degree of variability between patients.
Due to the development of an improved ARGS neoepitope an-
tibody, an BC3-C2/HABR ELISA was utilized to analysis human
articular cartilage explant samples and clinical patient urine sam-
ples. Approximately 500 pg/mL biomarker values were detected
in the ELISA, agreeing with data obtained from the IA/LC/MS/MS
data and literature reports.
Conclusions: The ARGSVIL peptide demonstrates high potential
as a drug activity biomarker of aggrecan degradation. Current
results validate its presence in human urine and demonstrate dose
response reduction with aggrecanase inhibition. This biomarker
promises to speed dose selection and predict target inhibition in
human clinical studies of aggrecanase inhibitors.
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DIURNAL VARIATION OF AMINO ACIDS AND
ACYLCARNITINES IN A COHORT WITH KNEE OA
D.K. Thompson, V.B. Kraus, R.J. Sloane
Duke Univ., Durham, NC
Purpose: Biomarker levels can ﬂuctuate in response to daily
activity, including feeding. In order to ascertain the degree and
direction of these changes, and in anticipation of investigating the
interaction of these agents with OA, markers of energy metabolism
were measured at various time points, including before and after
a mixed-nutrient meal.
Methods: 40 subjects with radiographic OA of at least one knee
were admitted overnight to the General Clinical Research Center
of Duke University to undergo serial serum sampling. Blood was
collected in the evening (T=3, 6-8pm, n=40), before rising from
bed or eating (T=0, 8am, n=40), 1 hour after rising but before
eating (T=1A, 9 am, n=20), 1-2 hours after rising and breakfast
(T=1, 9-10 am, n=40), and at noon (T=2, n=20). Breakfast included
protein, carbohydrate, and fat. Quantitative mass spectrometry of
15 amino acids (AAs), and 45 acyl carnitines (ACs), was performed
by stable-isotope dilution. The mean of the values for each time
point was normalized to the mean at baseline (T=0). Values for
acyl carnitines were log-transformed.
Results: All 15 amino acids displayed signiﬁcant (p<0.05)
changes between baseline and various time points ranging from 4-
43% (Table 1). The most notable increase occurred after consump-
tion of a mixed meal, when 14 AAs increased 7-23%. Statistically
signiﬁcant increases continued throughout the day for most AAs in
a monotonic pattern. Histidine showed the greatest stability, with
a statistically signiﬁcant change occurring only at T3 compared
to baseline (T0). Alanine, proline, valine, leucine/isoleucine, me-
thionine, phenylalanine, tyrosine, Aspartate/asparagine, ornithine,
and arginine varied signiﬁcantly in at least three of three of the
timepoints relative to baseline.
All 45 acylcarnitines (ACs) displayed statistically signiﬁcant
changes at various time points as compared to baseline (15
representative ACs shown in Table 2). Unlike AAs, which generally
displayed the same monotonic pattern to varying degrees, the
ACs varied widely in their diurnal proﬁles. The ACs also gener-
ally displayed smaller increases (typically 1-10%) as compared to
AAs (4-43%). Similar to AAs, an increase in serum concentration
was most common after ingestion of a mixed meal, as 31 ACs
displayed statistically signiﬁcant increases in the range of 1-16%.
Conclusions: From this preliminary study it is evident that major
classes of energy metabolites, including amino acids and acyl
carnitines, vary signiﬁcantly in response to normal daily activi-
ties including food intake. Elucidating these diurnal variations in
metabolites is an important early step in understanding the greater
complexities of energy balance. Furthermore, we hypothesize that
many of the agents of energy balance are intricately involved with
biomarkers of osteoarthritis, and deﬁning underlying metabolic
proﬁles will promote a more complete understanding of health
and disease states. Finally, of signiﬁcant practical importance, this
study underscores the need for researchers to plan deliberately
and act consistently when collecting samples for biomarker mea-
surement, since inconsistent sampling could introduce spurious
variations in the data.
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Purpose: Quantitative measurement of aggrecan fragments re-
leased from explants cultures is a validated model for the study
of metabolic processes relevant during cartilage degradation. We
wanted to investigate, if a new series of neo-epitope speciﬁc im-
munoassays could be applied in the proﬁling of aggrecanase-
and MMP-derived aggrecan fragments released into the super-
natant of articular cartilage explants originating from patients with
osteoarthritis.
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Methods: Human cartilage explants were cultured in the pres-
ence or absence of the catabolic cytokines oncostatin M (OSM)
and tumor necrosis factor alpha (TNFα). Fragments originating
from aggrecanase and MMP-mediated cleavage of aggrecan and
type II collagen and released into the supernatant was determined
using a range of neo-epitope speciﬁc immunoassays; (1) sandwich
342FFGVG-G2 ELISA, (2) competition NITEGE373ELISA (3) sand-
wich G1-NITEGE373 ELISA (4) competition 374ARGSV ELISA,
and (5) sandwich 374ARGSV-G2 ELISA all detecting aggrecan
fragments, and (6) sandwich CTX-II ELISA, which is speciﬁc for
the cross-linked neo-epitope EKGPDPxEKGPDP originating from
the C-telopeptide of type II collagen.
Results: We found that quantitatively the accumulated release of
aggrecanase- and MMP-derived aggrecan fragments was similar
in bovine and human cultures of articular cartilage upon stimula-
tion with catabolic cytoikines. However, in human cultures these
fragments were continuously released during all phases of the
21 day culturing period, whereas in bovine cultures MMP-derived
fragments were only observed in the late phase (day 16-21) and
aggrecanase-derived fragments in the early and mid phase.
Conclusions: Our data conﬁrm that major differences in bovine
and human processing of articular cartilage exist in response to
catabolic cytokines. This suggest that careful consideration should
given to the application of this ex vivo model in drug screening
programmes.
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SUPPRESSION OF MMP ACTIVITY IN BOVINE CARTILAGE
EXPLANTS CULTURES HAS LITTLE IF ANY EFFECT ON
THE RELEASE OF AGGRECAN FRAGMENTS CARRYING
AGGRECANASE-DERIVED NEO-EPITOPES, WHEREAS
CORRESPONDING MMP-DERIVED AGGRECAN AND
COLLAGEN FRAGMENTS ARE COMPLETELY ABOLISHED
FROM THE SUPERNATANT
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S.H. Madsen2, B.C. Sondergaard2, Q. Zheng1, P. Qvist2
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Purpose: Progressive loss of articular cartilage is a central hall-
mark in many joint disease, however, the relative importance of
individual proteolytic pathways leading to cartilage erosion is at
present unknown. In particular, the metabolic response induced by
the inhibition of MMPs remains to be investigated in appropriate
model systems, which also includes assessment of aggrecanase-
derived matrix degradation. We therefore investigated the time-
dependant release ex vivo of MMP- and aggrecanase-derived
fragments of aggrecan and type II collagen into the supernatant
of bovine cartilage explants cultures using neo-epitope speciﬁc
immunoassays, and to associate the release of these fragments
with the activity of proteolytic enzymes using inhibitors.
Methods: Bovine cartilage explants were cultured in the presence
or absence of the catabolic cytokines oncostatin M (OSM) and
tumor necrosis factor alpha (TNFα). In parallel, explants were co-
cultured with protease inhibitors such as GM6001, TIMP1, TIMP2
and TIMP3. Fragments originating from aggrecanase and MMP-
mediated cleavage of aggrecan and type II collagen and released
into the supernatant was determined using a range of neo-epitope
speciﬁc immunoassays; (1) sandwich 342FFGVG-G2 ELISA, (2)
competition NITEGE373ELISA (3) sandwich G1-NITEGE373 ELISA
(4) competition 374ARGSV ELISA, and (5) sandwich 374ARGSV-
G2 ELISA all detecting aggrecan fragments, and (6) sandwich
CTX-II ELISA, which is speciﬁc for the cross-linked neo-epitope
EKGPDPxEKGPDP originating from the C-telopeptide of type II
collagen.
Results: We found that (1) aggrecanase-derived aggrecan frag-
ments are released in the early (day 2-7) and mid phase (day
9-14) into the supernatant from bovine explants cultures stimu-
lated with catabolic cytokines, (2) the release of NITEGE373 neo-
epitopes are delayed compared to the corresponding 374ARGSV
fragments, (3) the MMP inhibitor GM6001 did not reduce the
release of aggrecanase-derived fragment, but induced a further
delay in the release of these fragments, (4) no signiﬁcant differ-
ences between aggrecan proﬁle obtained with competitive assays
vs corresponding sandwich assays could be detected, ﬁnally (5)
the MMP-derived aggrecan and type II collagen fragments were
released in the late phase (day 16-21) only.
Conclusions: Our data support the model, that aggrecanases
and MMPs act independently in the processing of the aggrecan
molecules, and furthermore that suppression of MMP-activity had
little if any effect on the quantity of aggrecanase-derived fragments
released from explants cultures.
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BIOMECHANICAL PROPERTIES OF THE BONE AND
CARTILAGE COMPARTMENTS IN A RAT KNEE OA MODEL
R.H. Nielsen1, M.A. Karsdal1, R. Ambat2
1Nordic BioSci. A/S, Herlev, Denmark; 2Technical Univ. of
Denmark, Lyngby, Denmark
Purpose: Osteoarthritis (OA) is a disease that affects the en-
tire articular joint, with both changes to the bone and cartilage
compartments.
Optimal biomechanical properties are pivotal for maintenance of
joint integrity and function. Altered biomechanical properties of
bone and cartilage are observed in OA disease and might add to
worsening of disease.
We investigated biomechanical properties of the bone and carti-
lage compartments in healthy and affected rat knees from an OA
model with combined traumatic knee surgery and increased bone
turnover.
Methods: Two groups each of 10 6-months old rats were sub-
jected to a combined ovariectomy and partial medial meniscec-
tomy (OVX+MNX) or sham surgery (SHAM).
Animals were sacriﬁced 8 weeks after surgery, and one tibia was
processed for biomechanical indentation testing. The tibias were
cast in Acrylﬁx-mould with the shaft ﬁxated in the mould and the
tibial plateau protruding.
Indentation test was performed centrally on the medial part of the
tibial plateau (Figure 1). An indenter area of 0.78 mm2 and a ﬁxed
Figure 1. AC: Articular cartilage; SBP: Subchondral bone plate; GP: Growth
plate; TB: Trabecular bone.
